홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
IBRX
#1050
ImmunityBio, Inc. Common Stock
7.4
6
USD
-1.84%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-1.84%
월간 변동
-12.44%
6달 변화
+186.92%
년간 변동율
+173.26%
이전 종가
7.6
0
Open
7.4
4
Bid
Ask
Low
7.4
4
High
7.4
8
양
222
마켓
주식
헬스케어
IBRX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
853.44 M
882.62 M
945.25 M
984.97 M
1.03 B
—
Valuation ratios
Enterprise value
2.33 B
2.89 B
2.67 B
2.68 B
2.27 B
10.52 B
Price to earnings ratio
-4.13
-5.28
-5.62
-6.15
-5.21
-22.26
Price to sales ratio
121.61
74.48
38.46
26.24
16.08
155.25
Price to cash flow ratio
-4.58
-5.9
-5.82
-6.39
-5.97
-24.09
Price to book ratio
-3.67
-0.87
-0.85
-0.95
-3.64
-6.31
EBITDA 비율에 대한 기업 가치
-7.25
-9.89
-10.07
-11.11
-9.62
-40.69
Profitability ratios
Return on assets %
-0.15
-0.43
-0.23
-0.13
-0.12
-0.91
Return on equity %
0.12
0.22
0.16
0.13
0.12
0.63
Return on invested capital %
-128.86
-120.21
-133.44
-103.38
-120.13
-477.16
Gross margin %
100
99.65
99.49
99.45
99
397.58
Operating margin %
-918.96
-390.08
-269.76
-173.51
-168.95
-1 002.3
EBITDA margin %
-864.17
-366.89
-255.08
-161.19
-158.86
-942.02
Net margin %
-783.4
-784.92
-350.26
-209.77
-161.8
-1 506.74
Liquidity ratios
Quick ratio
3.21
2.05
3.98
5.65
5.08
16.76
Current ratio
3.36
2.22
4.11
5.77
5.1
17.19
Inventory turnover
0
0.01
0.02
0.03
0.1
0.15
Asset turnover
0.02
0.05
0.07
0.07
0.08
0.27
Solvency ratios
Debt to assets ratio
0.74
0.98
0.76
0.61
0.65
3
Debt to equity ratio
-0.58
-0.5
-0.54
-0.61
-0.65
-2.3
Long term debt to total assets ratio
0.74
0.98
0.76
0.61
0.65
2.99
Long term debt to total equity ratio
-0.58
-0.5
-0.54
-0.6
-0.65
-2.29
Per share metrics
Operating cash flow per share
-0.12
-0.1
-0.09
-0.07
-0.08
-0.34
EBIT per share
-0.1
-0.08
-0.08
-0.06
-0.07
-0.28
EBITDA per share
-0.09
-0.07
-0.08
-0.05
-0.07
-0.27
Total debt per share
0.41
0.35
0.35
0.34
0.35
1.38
Cash per share
0.21
0.07
0.17
0.27
0.26
0.78
Net current asset value per share
0.26
0.13
0.23
0.35
0.34
1.05
Tangible book value per share
-0.72
-0.71
-0.66
-0.57
-0.56
-2.5
Working capital per share
0.19
0.07
0.18
0.29
0.28
0.81
Book value per share
-0.7
-0.69
-0.64
-0.55
-0.54
-2.43
뉴스
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
Why Is ImmunityBio Stock Rallying Thursday? - ImmunityBio (NASDAQ:IBRX)
ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold (NASDAQ:IBRX)
ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)
Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims
“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26% - TipRanks.com
ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy
ImmunityBio Crashes On FDA Warning Over Anktiva Claims - ImmunityBio (NASDAQ:IBRX)
Can Anktiva's Label Expansion Unlock the Next Growth Phase for IBRX?
ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion